Denise Galloway

Q: What Schools Are Affiliated With Denise Galloway

Denise Galloway is affiliated with the following schools: University of California, Berkeley, Stanford University, Saga University, University of Washington

Denise Galloway's AcademicInfluence.com Rankings

Denise Galloway

Biology

#7414

World Rank

#10334

Historical Rank

Microbiology

#471

World Rank

#532

Historical Rank

biology Degrees

Download Badge

Biology

Denise Galloway's Degrees

Bachelors Microbiology University of California, Berkeley
Masters Microbiology Stanford University

Why Is Denise Galloway Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Denise A. Galloway is the associate director of the Human Biology Division and scientific director of the Pathogen-Associated Malignancies Integrated Research Center at Fred Hutchinson Cancer Research Center, and a professor of microbiology and pathology at the University of Washington School of Medicine. Her research focuses on human papillomavirus and its role in the development of cancer.

(See a Problem?)

Denise Galloway's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells (1998) (1263)
Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer (2004) (754)
Epidemiology of genital human papillomavirus infection. (1988) (722)
Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis (1996) (679)
Non-transcriptional control of DNA replication by c-Myc (2007) (635)
Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. (1998) (634)
c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I (2005) (632)
The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells (1991) (592)
Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. (2000) (576)
Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. (1997) (550)
Penile cancer: Importance of circumcision, human papillomavirus and smoking in in situ and invasive disease (2005) (440)
Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins (1993) (423)
The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. (1996) (348)
Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. (1996) (326)
A population-based study of squamous cell vaginal cancer: HPV and cofactors. (2002) (320)
Papillomavirus E6 proteins. (2009) (319)
Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. (1996) (313)
The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells (1992) (291)
The oncogenic potential of herpes simplex viruses: evidence for a ‘hit-and-run’ mechanism (1983) (290)
Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex. (2004) (270)
Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. (2011) (266)
Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. (1996) (265)
Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. (2003) (262)
Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. (1994) (253)
Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. (1997) (242)
Association of Merkel Cell Polyomavirus–Specific Antibodies With Merkel Cell Carcinoma (2009) (240)
Inactivation of p16 in Human Mammary Epithelial Cells by CpG Island Methylation (1998) (238)
Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells. (1995) (227)
Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients. (2010) (218)
The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest (1994) (204)
E Box-Dependent Activation of Telomerase by Human Papillomavirus Type 16 E6 Does Not Require Induction of c-myc (2001) (198)
Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. (2001) (192)
Evidence of prevalent genital-type human papillomavirus infections in adults and children. (1990) (187)
Cofactors with human papillomavirus in a population-based study of vulvar cancer. (1997) (175)
Genital human papillomavirus infection in women who have sex with women. (1998) (164)
Defective G2 checkpoint function in cells from individuals with familial cancer syndromes. (1995) (164)
Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study. (1998) (160)
Risk for High-Grade Cervical Intraepithelial Neoplasia Associated with Variants of Human Papillomavirus Types 16 and 18 (2007) (156)
E6 Proteins from Multiple Human Betapapillomavirus Types Degrade Bak and Protect Keratinocytes from Apoptosis after UVB Irradiation (2008) (154)
Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. (2001) (152)
Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. (2006) (152)
Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors (2007) (151)
Destabilization of the Retinoblastoma Tumor Suppressor by Human Papillomavirus Type 16 E7 Is Not Sufficient To Overcome Cell Cycle Arrest in Human Keratinocytes (2001) (149)
Elevated wild-type p53 protein levels in human epithelial cell lines immortalized by the human papillomavirus type 16 E7 gene. (1994) (145)
Identification of an overprinting gene in Merkel cell polyomavirus provides evolutionary insight into the birth of viral genes (2013) (142)
Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids (1994) (142)
The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. (1996) (140)
Prevalence of genital papillomavirus infection among women attending a college student health clinic or a sexually transmitted disease clinic. (1989) (139)
Merkel Cell Polyomavirus-Specific CD8+ and CD4+ T-cell Responses Identified in Merkel Cell Carcinomas and Blood (2011) (138)
Induction of cytotoxic T lymphocytes specific for a syngeneic tumor expressing the E6 oncoprotein of human papillomavirus type 16. (1992) (134)
HPV 5 and 8 E6 Abrogate ATR Activity Resulting in Increased Persistence of UVB Induced DNA Damage (2012) (128)
Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation (1996) (127)
Progressive Region-Specific De Novo Methylation of the p16 CpG Island in Primary Human Mammary Epithelial Cell Strains during Escape from M0 Growth Arrest (1999) (120)
The G2 Checkpoint Is Maintained by Redundant Pathways (1999) (119)
Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study (2017) (119)
Disruption of the G1/S Transition in Human Papillomavirus Type 16 E7-Expressing Human Cells Is Associated with Altered Regulation of Cyclin E (1998) (119)
Lack of serologic evidence for prevalent simian virus 40 infection in humans. (2004) (112)
Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk. (2008) (112)
Papillomavirus vaccines in clinical trials. (2003) (111)
Cervical carcinoma: Detection of herpes simplex virus RNA in cells undergoing neoplastic change (1980) (111)
Inactivation of both the Retinoblastoma Tumor Suppressor and p21 by the Human Papillomavirus Type 16 E7 Oncoprotein Is Necessary To Inhibit Cell Cycle Arrest in Human Epithelial Cells (2002) (111)
Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. (1995) (110)
Normal Human Fibroblasts Are Resistant to RAS-Induced Senescence (2004) (108)
Detection of herpes simplex RNA in human sensory ganglia. (1979) (106)
Anal human papillomavirus infection among human immunodeficiency virus-seropositive and -seronegative men. (1990) (104)
Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design (2016) (103)
Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix. (2001) (103)
Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students. (2002) (100)
Identification of a Human Papillomavirus Type 16-Specific Epitope on the C-Terminal Arm of the Major Capsid Protein L1 (2003) (95)
Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants. (1998) (95)
Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coli-expressed fusion proteins (1988) (93)
Human papillomaviruses and carcinomas. (1989) (93)
Transformation of NIH 3T3 cells with cloned fragments of human cytomegalovirus strain AD169 (1982) (92)
The E7 protein of human papillomavirus type 16 is phosphorylated by casein kinase II. (1989) (91)
Efficient immortalization of primary human cells by p16INK4a‐specific short hairpin RNA or Bmi‐1, combined with introduction of hTERT (2007) (90)
Beta-HPV 5 and 8 E6 Promote p300 Degradation by Blocking AKT/p300 Association (2011) (89)
Limited transcription of the herpes simplex virus genome when latent in human sensory ganglia (1982) (89)
Human leukocyte antigen class II and cervical cancer risk: a population-based study. (2002) (86)
The E6 Oncoproteins from Human Betapapillomaviruses Differentially Activate Telomerase through an E6AP-Dependent Mechanism and Prolong the Lifespan of Primary Keratinocytes (2008) (85)
Nucleotide sequence of the herpes simplex virus type 2 thymidine kinase gene (1983) (83)
Human papillomaviruses: shared and distinct pathways for pathogenesis. (2015) (82)
Structure of the transforming region of human cytomegalovirus AD169 (1984) (82)
c-Myc Accelerates S-Phase and Requires WRN to Avoid Replication Stress (2009) (81)
NFX1-123 and Poly(A) Binding Proteins Synergistically Augment Activation of Telomerase in Human Papillomavirus Type 16 E6-Expressing Cells (2007) (79)
Characterization of the gene encoding herpes simplex virus type 2 glycoprotein C and comparison with the type 1 counterpart (1985) (77)
Identification of Human Papillomavirus Type 16 L1 Surface Loops Required for Neutralization by Human Sera (2006) (74)
The disruption of cell cycle checkpoints by papillomavirus oncoproteins contributes to anogenital neoplasia. (1996) (73)
Transformation of rodent cells by a cloned DNA fragment of herpes simplex virus type 2 (1981) (72)
NFX1 Interacts with mSin3A/Histone Deacetylase To Repress hTERT Transcription in Keratinocytes (2008) (71)
Serum antibody response following genital {alpha}9 human papillomavirus infection in young men. (2011) (70)
Herpes simplex virus specifies two subunits of ribonucleotide reductase encoded by 3'-coterminal transcripts (1986) (68)
Generation of a human melanocyte cell line by introduction of HPV16 E6 and E7 genes (1997) (67)
Detection of cervical antibodies to human papillomavirus type 16 (HPV-16) capsid antigens in relation to detection of HPV-16 DNA and cervical lesions. (2000) (66)
Manipulation of cellular DNA damage repair machinery facilitates propagation of human papillomaviruses. (2014) (66)
Viral load in the natural history of human papillomavirus type 16 infection: a nested case-control study. (2011) (65)
Serologic evidence of human papillomavirus 16 and 18 infections and risk of prostate cancer. (2003) (62)
Inactivation of G2 checkpoint function and chromosomal destabilization are linked in human fibroblasts expressing human papillomavirus type 16 E6. (1997) (62)
Small fragments of herpesvirus DNA with transforming activity contain insertion sequence-like structures. (1984) (62)
Identification of the E5 open reading frame of human papillomavirus type 16 (1988) (62)
Induction of Extracellular Matrix-Remodeling Genes by the Senescence-Associated Protein APA-1 (2002) (59)
High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway (2017) (59)
Human antibodies react with an epitope of the human papillomavirus type 6b L1 open reading frame which is distinct from the type-common epitope (1989) (59)
NFX1-123 Increases hTERT Expression and Telomerase Activity Posttranscriptionally in Human Papillomavirus Type 16 E6 Keratinocytes (2009) (57)
Human papillomavirus type 16 E7 alleviates a proliferation block in early passage human mammary epithelial cells. (1996) (57)
The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer. (2000) (57)
Characteristics of Memory B Cells Elicited by a Highly Efficacious HPV Vaccine in Subjects with No Pre-existing Immunity (2014) (56)
Cloning and characterization of oriL2, a large palindromic DNA replication origin of herpes simplex virus type 2 (1986) (55)
Sequence and structural requirements of a herpes simplex viral DNA replication origin (1988) (55)
Seroprevalence of human papillomavirus types 6 and 16 capsid antibodies in homosexual men. (1997) (52)
Characterization of human antibody-reactive epitopes encoded by human papillomavirus types 16 and 18 (1991) (51)
Beta Human Papillomavirus E6 Expression Inhibits Stabilization of p53 and Increases Tolerance of Genomic Instability (2014) (51)
Predicted alpha-helix/beta-sheet secondary structures for the zinc-binding motifs of human papillomavirus E7 and E6 proteins by consensus prediction averaging and spectroscopic studies of E7. (1996) (50)
Humoral immune response to human papillomavirus infection. (1997) (49)
Detection of human papillomavirus capsid antigens in various squamous epithelial lesions using antibodies directed against the L1 and L2 open reading frames. (1988) (49)
The E 7 Gene of Human Papillomavirus Type 16 Is Sufficient for Immortalization of Human Epithelial Cells (47)
Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States. (2004) (46)
Herpesvirus-specific RNA and protein in carcinoma of the uterine cervix. (1982) (46)
Preferential radiosensitization of G1 checkpoint-deficient cells by methylxanthines. (1996) (46)
The E6 protein of human papillomavirus type 16 functions as a transcriptional repressor in a mechanism independent of the tumor suppressor protein, p53. (1994) (45)
Is vaccination against human papillomavirus a possibility? (1998) (45)
Novel Functions of the Human Papillomavirus E6 Oncoproteins. (2015) (45)
Characterization of IgA response among women with incident HPV 16 infection. (2003) (42)
Inhibiting CDK inhibitors: new lessons from DNA tumor viruses. (1998) (42)
A Single Human Papillomavirus Vaccine Dose Improves B Cell Memory in Previously Infected Subjects (2016) (41)
Identification of proteins encoded by a fragment of herpes simplex virus type 2 DNA that has transforming activity (1982) (40)
Simian virus 40 (SV40) and human cancer: a review of the serological data (2004) (39)
Immunological cross-reactivity to laboratory-produced HPV-11 virions of polysera raised against bacterially derived fusion proteins and synthetic peptides of HPV-6b and HPV-16 capsid proteins. (1990) (39)
β-HPV 5 and 8 E6 Disrupt Homology Dependent Double Strand Break Repair by Attenuating BRCA1 and BRCA2 Expression and Foci Formation (2015) (39)
Cervical and Vulvar Cancer Risk in Relation to the Joint Effects of Cigarette Smoking and Genetic Variation in Interleukin 2 (2008) (38)
Sequence variation in the noncoding region of human papillomavirus type 16 detected by single-strand conformation polymorphism analysis. (1993) (37)
Characterization of the humoral immune response to genital papillomaviruses. (1990) (37)
Use of HPV 1 capsids produced by recombinant vaccinia viruses in an ELISA to detect serum antibodies in people with foot warts. (1994) (37)
Cytoplasmic Poly(A) Binding Proteins Regulate Telomerase Activity and Cell Growth in Human Papillomavirus Type 16 E6-Expressing Keratinocytes (2010) (37)
The Normal Response to RAS: Senescence or Transformation? (2004) (37)
Human leukocyte antigen class II alleles in Caucasian women with primary biliary cirrhosis. (2005) (37)
Identification of CIP-1-associated Regulator of Cyclin B (CARB), a Novel p21-binding Protein Acting in the G2 Phase of the Cell Cycle* (2000) (36)
Serologic evidence of herpes simplex virus 1 infection and oropharyngeal cancer risk. (2001) (36)
Comparison of Southern transfer hybridization and dot filter hybridization for detection of cervical human papillomavirus infection with types 6, 11, 16, 18, 31, 33, and 35. (1990) (35)
Epigenetic Down-Regulation of ARF Expression Is a Selection Step in Immortalization of Human Fibroblasts by c-Myc (2007) (35)
Humoral Immune Response Recognizes a Complex Set of Epitopes on Human Papillomavirus Type 6 L1 Capsomers (2005) (35)
HPV 5 and 8 E6 expression reduces ATM protein levels and attenuates LINE-1 retrotransposition. (2013) (35)
Organization of the left-hand end of the herpes simplex virus type 2 BglII N fragment (1984) (35)
p21CIP1 is not required for the early G2 checkpoint response to ionizing radiation. (1995) (34)
Expression of human papillomavirus proteins in yeast Saccharomyces cerevisiae. (1991) (34)
HPV-1 capsids expressed in vitro detect human serum antibodies associated with foot warts. (1993) (34)
Metastatic conversion of cells by expression of human papillomavirus type 16 E6 and E7 genes. (1993) (34)
NFX1 Plays a Role in Human Papillomavirus Type 16 E6 Activation of NFκB Activity (2010) (33)
No Evidence for Human Papillomavirus in the Etiology of Colorectal Polyps (2011) (33)
Nucleotide variation in IL‐10 and IL‐12 and their receptors and cervical and vulvar cancer risk: A hybrid case–parent triad and case–control study (2013) (33)
Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies. (2009) (33)
Redetection of cervical human papillomavirus type 16 (HPV16) in women with a history of HPV16. (2013) (33)
Analysis of viral DNA sequences in hamster cells transformed by herpes simplex virus type 2. (1980) (33)
Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3. (2009) (32)
Antibody responses in oral fluid after administration of prophylactic human papillomavirus vaccines. (2009) (32)
Genetic variation in the TLR and NF‐κB pathways and cervical and vulvar cancer risk: A population‐based case–control study (2014) (32)
Latency of Pseudorabies Virus (1984) (32)
Type‐dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18 (2017) (31)
Alterations in the cellular phenotype induced by herpes simplex viruses (1990) (31)
Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM, and mucosal IgA antibodies. (1995) (31)
Regulation of telomerase by human papillomaviruses. (2005) (30)
Effect of cervical cytologic status on the association between human papillomavirus type 16 DNA load and the risk of cervical intraepithelial neoplasia grade 3. (2008) (29)
HLA allelic variants encoding DR11 in diffuse and limited systemic sclerosis in Caucasian women. (2005) (29)
Human papilloma viruses (2012) (29)
Age of Diagnosis of Squamous Cell Cervical Carcinoma and Early Sexual Experience (2009) (28)
Papillomavirus capsids: a new approach to identify serological markers of HPV infection. (1994) (28)
Characterization of murine polyclonal antisera and monoclonal antibodies generated against intact and denatured human papillomavirus type 1 virions (1991) (28)
Risk of Cervical Cancer Associated with Allergies and Polymorphisms in Genes in the Chromosome 5 Cytokine Cluster (2010) (27)
Plasmid mediated mutagenesis of a cellular gene in transfected eukaryotic cells. (1987) (26)
An unbiased in vivo screen reveals multiple transcription factors that control HPV E6-regulated hTERT in keratinocytes. (2013) (25)
The association of human papillomavirus antibodies with cervical cancer risk. (1992) (25)
Re‐detection vs. new acquisition of high‐risk human papillomavirus in mid‐adult women (2016) (24)
Cloning of Herpes simplex virus type 2 DNA fragments in a plasmid vector (1980) (24)
Human antibodies recognize multiple distinct type-specific and cross-reactive regions of the minor capsid proteins of human papillomavirus types 6 and 11 (1992) (23)
A population-based case-control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancers. (2015) (23)
Human papillomavirus-associated cancers. (2010) (23)
Location and cloning of the herpes simplex virus type 2 thymidine kinase gene (1980) (22)
Model-estimated effectiveness of single dose 9-valent HPV vaccination for HIV-positive and HIV-negative females in South Africa. (2018) (22)
Comparative virologic studies of condylomata acuminata reveal a lack of dual infections with human papillomaviruses. (1991) (21)
HSV, CMV, and HPV in human neoplasia. (1984) (21)
Type specific and genotype cross reactive B epitopes of the L1 protein of HPV16 defined by a panel of monoclonal antibodies. (1998) (21)
Effect of Human Papillomavirus Vaccine to Interrupt Recurrence of Vulvar and Anal Neoplasia (VIVA) (2019) (20)
Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development (2009) (20)
Risk of squamous cell skin cancer after organ transplant associated with antibodies to cutaneous papillomaviruses, polyomaviruses, and TMC6/8 (EVER1/2) variants (2014) (20)
Merkel cell polyomavirus Tumor antigens expressed in Merkel cell carcinoma function independently of the ubiquitin ligases Fbw7 and β-TrCP (2019) (19)
FOXM1 drives HPV+ HNSCC sensitivity to WEE1 inhibition (2020) (19)
Efficacy of single-dose HPV vaccination among young African women (2021) (19)
Identification of recombinant human papillomavirus type 16 variants. (2009) (19)
Serological and molecular evidence of rhesus papillomavirus type 1 infections in tissues from geographically distinct institutions. (1995) (18)
Functional Link Between Myc and the Werner Gene in Tumorigenesis (2004) (17)
Degradation of ATM-Independent Decatenation Checkpoint Function in Human Cells is Secondary to Inactivation of p53 and Correlated with Chromosomal Destabilization (2002) (17)
High-risk human papillomavirus oncogenes disrupt the Fanconi anemia DNA repair pathway by impairing localization and de-ubiquitination of FancD2 (2019) (17)
Quadrivalent HPV vaccine in HIV-1-infected early adolescent girls and boys in Kenya: Month 7 and 12 post vaccine immunogenicity and correlation with immune status. (2018) (15)
Comparison of oral fluid and serum ELISAs in the determination of IgG response to natural human papillomavirus infection in university women. (2006) (15)
Skin and Mucosal Human Papillomavirus Seroprevalence in Persons with Fanconi Anemia (2015) (14)
Cloning and Characterization of oriL 2 , a Large Palindromic DNA Replication Origin of Herpes Simplex Virus Type 2 (14)
Single-dose HPV vaccination efficacy among adolescent girls and young women in Kenya (the KEN SHE Study): study protocol for a randomized controlled trial (2021) (14)
Cell cycle checkpoint control is bypassed by human papillomavirus oncogenes. (1994) (14)
Papillomavirus oncoproteins as vaccine candidates (1996) (14)
Absence of an association of human polyomavirus and papillomavirus infection with lung cancer in China: a nested case–control study (2016) (13)
Serological assays for the detection of HPV antibodies. (1992) (13)
Sequence and antigenic diversity in two immunodominant regions of the L2 protein of human papillomavirus types 6 and 16. (1993) (13)
Prior human polyomavirus and papillomavirus infection and incident lung cancer: a nested case–control study (2015) (13)
Genomic Variation of Human Papillomavirus Type 16 and Risk for High-Grade Cervical Intraepithelial Neoplasia (1998) (13)
Variant‐specific persistence of infections with human papillomavirus Types 31, 33, 45, 56 and 58 and risk of cervical intraepithelial neoplasia (2016) (13)
163 Abrogation of the G2 checkpoint by methylxanthines results in differential radiosensitization of G1 checkpoint — deficient and G1 checkpoint — Competent A549 human lung cancer cells (1995) (12)
Cohort profile: the skin cancer after organ transplant study. (2013) (12)
Progressive Region-Speciﬁc De Novo Methylation of the p16 CpG Island in Primary Human Mammary Epithelial Cell Strains during Escape from M 0 Growth Arrest (1999) (12)
Herpes simplex virus types 1 and 2 homology in the region between 0.58 and 0.68 map units (1984) (12)
Characterization of ALTO-encoding circular RNAs expressed by Merkel cell polyomavirus and trichodysplasia spinulosa polyomavirus (2021) (11)
Human papillomaviruses: a growing field. (2009) (10)
Transformation of rat cells by the hybrid virus Ad2(2+) HEY. (1979) (10)
Detection of nucleic acid sequences in cervical tumors. (1981) (10)
Gene expression signature of c-MYC-immortalized human fibroblasts reveals loss of growth inhibitory response to TGFβ (2011) (9)
Analysis of Memory B-Cell Responses Reveals Suboptimal Dosing Schedule of a Licensed Vaccine (2017) (8)
Detection of human papillomavirus in the oral cavities of persons with Fanconi anemia. (2015) (8)
Natural Antibodies to Human Papillomavirus 16 and Recurrence of Vulvar High-Grade Intraepithelial Neoplasia (VIN3) (2016) (8)
Generation of a cost-effective cell line for support of high-throughput isolation of primary human B cells and monoclonal neutralizing antibodies (2020) (8)
Human papillomavirus vaccines: a warty problem. (1994) (8)
Navigating the descent into papillomavirus hell. (1994) (7)
A history of allergies is associated with reduced risk of oral squamous cell carcinoma (2012) (6)
Determinants of High-Risk Human Papillomavirus Seroprevalence and DNA Prevalence in Mid-Adult Women (2016) (5)
Characterization of the integration site of the CMV mtr in a tumor cell line. (1987) (4)
DEFINED VIRAL PROBES FOR THE DETECTION OF HSV, CMV AND HPV (1985) (4)
Defective G 2 Checkpoint Function in Cells from Individuals with Familial Cancer Syndromes 1 (2006) (4)
NFX 1123 Increases hTERT Expression and Telomerase Activity Posttranscriptionally in Human Papillomavirus Type 16 E 6 Keratinocytes (2009) (4)
Is the evidence implicating human papillomavirus type 16 in esophageal cancer hard to swallow? (1996) (4)
Viral Oncogenesis: Infections that Can Lead to Cancer (2016) (4)
Human Epithelial Cells Necessary To Inhibit Cell Cycle Arrest in Papillomavirus Type 16 E 7 Oncoprotein Is Tumor Suppressor and p 21 by the Human Inactivation of both the Retinoblastoma (2002) (4)
Virology under the Microscope—a Call for Rational Discourse (2023) (4)
In Situ Cytological Hybridization to Detect Herpes Simplex Virus RNA in Human Tissues (1979) (3)
Use of amphotropic retroviruses expressing human papillomavirus 16 E6 and E7 to determine the consequences of acute expression of the viral oncogenes and to establish immortalized human cell lines (1995) (3)
B Cell Responses upon Human Papillomavirus (HPV) Infection and Vaccination (2022) (3)
Changes in DNA Level of Oncogenic Human Papillomaviruses Other Than Types 16 and 18 in Relation to Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3 (2019) (3)
590 Detecting Merkel cell carcinoma recurrence using a blood test: Outcomes from 774 patients (2019) (3)
The Humoral Immune Response to Human Papillomavirus (2007) (3)
Correction: Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design (2016) (3)
Kaposi’s Sarcoma-Associated Transforming Sequences (1988) (2)
DISRUPTION OF CELL CYCLE CONTROL BY HUMAN PAPILLOMAVIRUSES (1999) (2)
Transformation ofRodent Cells byaCloned DNA Fragment ofHerpes Simplex Virus Type2 (1981) (2)
Intrastrand self-complementary sequences in Bacillus subtilis DNA. (1979) (1)
HPV-16 E 7 ? oncoprotein Inhibition of CDK activity and PCNA-dependent DNA replication (1997) (1)
Virology under the Microscope—a Call for Rational Discourse (2023) (1)
Virology under the Microscope—a Call for Rational Discourse (2023) (1)
Stopping HPVs dead in their tracts. (2010) (1)
Human Papillomavirus and Long-term Oral Contraceptive Use Increase the Risk of Adenocarcinoma in Situ of the Cervix 1 (2001) (1)
Barriers to Human Papillomavirus Vaccine Series Completion among Insured Individuals in an Integrated Healthcare Setting (2021) (1)
ReqUÂ ¡ redfor fj , e Early G 2 Checkpoint Response to Ionizing Radiation (2006) (0)
Checkpoint-competent Cells 1 Checkpoint-deficient and G 1 Radiosensitization of G Checkpoint Results in Differential 2 Abrogation of the G Updated (2006) (0)
Human papilloma viruses (2012) (0)
Abstract PR07: WEE1 inhibition triggers premature mitotic entry in HPV16-E6-expressing cells independent of p53 inactivation (2020) (0)
Papillomaviruses Human papillomavirus ( HPV ) (2017) (0)
A history of allergies is associated with reduced risk of oral squamous cell carcinoma (2012) (0)
Absence of an association of human polyomavirus and papillomavirus infection with lung cancer in China: a nested case–control study (2016) (0)
Early G 2 Checkpoint Response to Ionizing Radiation (2006) (0)
Normal human melanocytes immortalized by HPV16E6E7 genes: generation of melanocyte cell line PIG1 (1995) (0)
Detection of Viral Nucleic-Acid Sequences Using Insitu Cytological Hybridization (1978) (0)
Transforming properties of human cytomegalovirus (1987) (0)
Location andCloning oftheHerpes Simplex Virus Type2 Thymidine Kinase Gene (1980) (0)
High-Risk Human Papillomavirus Oncogenes Disrupt the Fanconi Anemia DNA repair Pathway by Impairing Localization and Deubiquitination of FancD2 (2018) (0)
Understanding the Interaction Between Merkel Cell Polyomavirus Small T Antigen and Delta-Catenin (2022) (0)
NFX1 Interacts with mSin3A/Histone Deacetylase To Repress hTERT Transcription in Keratinocytes (2008) (0)
Vaccines Against Virally Induced Cancers - Final Discussion (1994) (0)
101. Effect of Human Papillomavirus Vaccine to Interrupt Recurrence of Vulvar and Anal Neoplasia (VIVA): A Randomized, Placebo-Controlled Trial (2022) (0)
The Murky Life of Merkel Cell Polyomavirus. (2016) (0)
Human Papillomavirus Antibodies Differ in Men and Women with Anal Cancer (2008) (0)
Cancer esearch oenvironment and Immunology ibodies to Merkel Cell Polyomavirus T Antigen oproteins Reflect Tumor Burden in Merkel R l Carcinoma Patients (2010) (0)
Short Communication Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies (2009) (0)
Prior human polyomavirus and papillomavirus infection and incident lung cancer: a nested case–control study (2015) (0)
Metastatic conversion of cells by expression of human papillomavirus type 16 E 6 and E 7 genes ( malignancy / transformadon / tumorigenidty / cancer metastasis ) (2005) (0)
Structural Characterization of Immune Responses to HPV Infection and HPV Vaccination (2019) (0)
What is the risk of Merkel cell carcinoma recurrence beyond pathologically clear margins? An analysis of 926 cases (MCC).Methods:Herein,weanalyzeddatafrom80patientsinaSeattle-basedIRB-approvedregistrywhohadsurgicalexcisionwithpathologicallyclearmargins,negativesentinellymphnodebiopsy,andnolocaladjuv (0)
Analysis of liquid bead microarray antibody assay data for epidemiologic studies of pathogen-cancer associations. (2015) (0)
actinomycin D-induced growth arrest. correlates with their ability to abrogate proteins to target p53 for degradation in vivo The ability of human papillomavirus E6 (2013) (0)
Abstract 58: Therapeutically targeting the cell cycle in head and neck cancer (2017) (0)
Familial Cancer Syndromes Checkpoint Function in Cells from Individuals with 2 Defective G Updated (2006) (0)
Escherichia coli-expressed fusion proteins. human papillomavirus type 6b by using Identification of immunoreactive antigens of (2013) (0)
Herpes Simplex Viral DNA Replication Origin (0)
Characterization of novel protein interactions in the P21CIP1 pathway of cell cycle control (1998) (0)
Humoral Response to HPV16 Proteins in Persons with Anal High-Grade Squamous Intraepithelial Lesion or Anal Cancer (2020) (0)
Analysis ofviral DNA sequences inhamster cells transformed by herpes simplex virus type2 (1980) (0)
Cloning of Herpes simplex virus 2 DNA fragments in a plasmid vector. (1980) (0)

This paper list is powered by the following services:

Other Resources About Denise Galloway

en.wikipedia.org

What Schools Are Affiliated With Denise Galloway?

Denise Galloway is affiliated with the following schools:

Denise Galloway's Academic­Influence.com Rankings